• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞膜伪装纳米颗粒介导的核酸递送。

Cell Membrane-Camouflaged Nanoparticles Mediated Nucleic Acids Delivery.

机构信息

Pharmacy Department & Panyu Institute of Infectious Diseases, Guangzhou Panyu Central Hospital, Guangzhou, Guangdong, 511400, People's Republic of China.

Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, 511436, People's Republic of China.

出版信息

Int J Nanomedicine. 2023 Dec 28;18:8001-8021. doi: 10.2147/IJN.S433737. eCollection 2023.

DOI:10.2147/IJN.S433737
PMID:38164266
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10758188/
Abstract

Nucleic acids have emerged as promising therapeutic agents for many diseases because of their potential in modulating gene expression. However, the delivery of nucleic acids remains a significant challenge in gene therapy. Although viral vectors have shown high transfection efficiency, concerns regarding teratogenicity or carcinogenicity have been raised. Non-viral vehicles, including cationic polymers, liposomes, and inorganic materials possess advantages in terms of safety, ease of preparation, and low cost. Nevertheless, they also face limitations related to immunogenicity, quick clearance in vivo, and lack of targeting specificity. On the other hand, bioinspired strategies have shown increasing potential in the field of drug delivery, yet there is a lack of comprehensive reviews summarizing the rapid development of bioinspired nanoparticles based on the cell membrane camouflage to construct the nucleic acids vehicles. Herein, we enumerated the current difficulties in nucleic acid delivery with various non-viral vehicles and provided an overview of bioinspired strategies for nucleic acid delivery.

摘要

核酸因其在调节基因表达方面的潜力,已成为许多疾病有前途的治疗药物。然而,核酸的递送仍然是基因治疗中的一个重大挑战。尽管病毒载体显示出高转染效率,但人们对其致畸性或致癌性表示担忧。非病毒载体,包括阳离子聚合物、脂质体和无机材料,在安全性、易于制备和低成本方面具有优势。然而,它们也面临着与免疫原性、体内快速清除和缺乏靶向特异性相关的限制。另一方面,仿生策略在药物输送领域显示出越来越大的潜力,但缺乏全面的综述,总结基于细胞膜伪装构建核酸载体的仿生纳米粒子的快速发展。在此,我们列举了各种非病毒载体在核酸传递方面的当前困难,并概述了核酸传递的仿生策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/39f6dbce98b3/IJN-18-8001-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/a6542321b3a5/IJN-18-8001-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/60a7a1d6c765/IJN-18-8001-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/78d434c9ca39/IJN-18-8001-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/4d7248ef1c29/IJN-18-8001-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/b6947f536d21/IJN-18-8001-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/a2310d2b5fd8/IJN-18-8001-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/e7e54942e1e0/IJN-18-8001-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/592381b33dcf/IJN-18-8001-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/f101833aa07f/IJN-18-8001-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/39f6dbce98b3/IJN-18-8001-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/a6542321b3a5/IJN-18-8001-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/60a7a1d6c765/IJN-18-8001-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/78d434c9ca39/IJN-18-8001-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/4d7248ef1c29/IJN-18-8001-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/b6947f536d21/IJN-18-8001-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/a2310d2b5fd8/IJN-18-8001-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/e7e54942e1e0/IJN-18-8001-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/592381b33dcf/IJN-18-8001-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/f101833aa07f/IJN-18-8001-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f269/10758188/39f6dbce98b3/IJN-18-8001-g0010.jpg

相似文献

1
Cell Membrane-Camouflaged Nanoparticles Mediated Nucleic Acids Delivery.细胞膜伪装纳米颗粒介导的核酸递送。
Int J Nanomedicine. 2023 Dec 28;18:8001-8021. doi: 10.2147/IJN.S433737. eCollection 2023.
2
Recent advances in nonviral vectors for gene delivery.基因传递的非病毒载体的最新进展。
Acc Chem Res. 2012 Jul 17;45(7):971-9. doi: 10.1021/ar200151m. Epub 2011 Aug 26.
3
Peptide vectors for the nonviral delivery of nucleic acids.肽载体用于非病毒递送核酸。
Acc Chem Res. 2012 Jul 17;45(7):1048-56. doi: 10.1021/ar2002304. Epub 2012 Mar 28.
4
A comprehensive review of cancer therapies mediated by conjugated gold nanoparticles with nucleic acid.共轭金纳米粒子介导的核酸癌症治疗的综合评述。
Int J Biol Macromol. 2023 Dec 31;253(Pt 5):127184. doi: 10.1016/j.ijbiomac.2023.127184. Epub 2023 Oct 3.
5
Peptide and nucleic acid-directed self-assembly of cationic nanovehicles through giant unilamellar vesicle modification: Targetable nanocomplexes for in vivo nucleic acid delivery.通过巨单层囊泡修饰实现阳离子纳米载体的肽和核酸定向自组装:用于体内核酸递送的靶向纳米复合物。
Acta Biomater. 2017 Mar 15;51:351-362. doi: 10.1016/j.actbio.2017.01.048. Epub 2017 Jan 18.
6
Microfluidic fabrication of lipid nanoparticles for the delivery of nucleic acids.微流控技术制备用于核酸递送的脂质纳米粒。
Adv Drug Deliv Rev. 2022 May;184:114197. doi: 10.1016/j.addr.2022.114197. Epub 2022 Mar 12.
7
Cationic nanoemulsions as nucleic acids delivery systems.阳离子纳米乳作为核酸传递系统。
Int J Pharm. 2017 Dec 20;534(1-2):356-367. doi: 10.1016/j.ijpharm.2017.10.030. Epub 2017 Oct 13.
8
Cationic cycloamylose based nucleic acid nanocarriers.基于阳离子环糊精的核酸纳米载体。
Chem Biol Interact. 2024 May 25;395:111000. doi: 10.1016/j.cbi.2024.111000. Epub 2024 Apr 12.
9
Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers.用于基因递送的化学载体:关于含组氨酸或咪唑的聚合物、肽和脂质作为核酸载体的当前综述。
Br J Pharmacol. 2009 May;157(2):166-78. doi: 10.1111/j.1476-5381.2009.00288.x.
10
Nonviral approach for targeted nucleic acid delivery.非病毒方法靶向核酸递送。
Curr Med Chem. 2012;19(2):197-208. doi: 10.2174/092986712803414141.

引用本文的文献

1
Application of Biomimetic Cell Membrane-Coated Nanocarriers in Cardiovascular Diseases.仿生细胞膜包覆纳米载体在心血管疾病中的应用
Int J Nanomedicine. 2025 Jun 26;20:8249-8289. doi: 10.2147/IJN.S531558. eCollection 2025.
2
Advances and prospects of RNA delivery nanoplatforms for cancer therapy.用于癌症治疗的RNA递送纳米平台的进展与展望
Acta Pharm Sin B. 2025 Jan;15(1):52-96. doi: 10.1016/j.apsb.2024.09.009. Epub 2024 Sep 14.
3
Dual targeting and bioresponsive nano-PROTAC induced precise and effective lung cancer therapy.

本文引用的文献

1
Biomimetic Epigallocatechin Gallate-Cerium Assemblies for the Treatment of Rheumatoid Arthritis.仿生表没食子儿茶素没食子酸酯-铈组装体治疗类风湿性关节炎。
ACS Appl Mater Interfaces. 2023 Jul 19;15(28):33239-33249. doi: 10.1021/acsami.3c02768. Epub 2023 Jul 3.
2
Macrophage-Cancer Hybrid Membrane-Camouflaged Nanoplatforms for HIF-1α Gene Silencing-Enhanced Sonodynamic Therapy of Glioblastoma.巨噬细胞-癌症杂化膜伪装纳米平台用于 HIF-1α 基因沉默增强的脑胶质瘤声动力学治疗。
ACS Appl Mater Interfaces. 2023 Jul 5;15(26):31150-31158. doi: 10.1021/acsami.3c03001. Epub 2023 Jun 20.
3
Adenine transversion editors enable precise, efficient A•T-to-C•G base editing in mammalian cells and embryos.
双靶标和生物响应性纳米-PROTAC 诱导精准有效的肺癌治疗。
J Nanobiotechnology. 2024 Nov 10;22(1):692. doi: 10.1186/s12951-024-02967-7.
腺嘌呤颠换编辑器可在哺乳动物细胞和胚胎中实现精确、高效的 A•T 到 C•G 碱基编辑。
Nat Biotechnol. 2024 Apr;42(4):638-650. doi: 10.1038/s41587-023-01821-9. Epub 2023 Jun 15.
4
Biomimetic Nanoparticle with Glutathione Depletion and Amplified ROS Generation Capabilities for Synergistic Chemo-Sonodynamic Therapy in Squamous Cell Carcinomas.具有谷胱甘肽耗竭和增强 ROS 生成能力的仿生纳米粒子用于鳞状细胞癌的协同化疗-声动力学治疗。
ACS Appl Mater Interfaces. 2023 Jun 7;15(22):27183-27194. doi: 10.1021/acsami.3c03792. Epub 2023 May 23.
5
Bioinspired PROTAC-induced macrophage fate determination alleviates atherosclerosis.仿生 PROTAC 诱导巨噬细胞命运决定减轻动脉粥样硬化。
Acta Pharmacol Sin. 2023 Oct;44(10):1962-1976. doi: 10.1038/s41401-023-01088-5. Epub 2023 May 11.
6
A bionic "Trojan horse"-like gene delivery system hybridized with tumor and macrophage cell membrane for cancer therapy.一种仿生的“木马”样基因传递系统,与肿瘤和巨噬细胞膜杂交,用于癌症治疗。
J Control Release. 2023 Jun;358:204-218. doi: 10.1016/j.jconrel.2023.04.046. Epub 2023 May 4.
7
Ultrasound-assisted biomimetic nanobubbles for targeted treatment of atherosclerosis.超声辅助仿生纳米气泡用于动脉粥样硬化的靶向治疗。
Nanomedicine. 2023 Jul;51:102682. doi: 10.1016/j.nano.2023.102682. Epub 2023 Apr 25.
8
Ultrasound Responsive Nanovaccine Armed with Engineered Cancer Cell Membrane and RNA to Prevent Foreseeable Metastasis.超声响应型纳米疫苗,用工程化癌细胞膜和 RNA 武装,以预防可预见的转移。
Adv Sci (Weinh). 2023 Jul;10(19):e2301107. doi: 10.1002/advs.202301107. Epub 2023 Apr 25.
9
Genetically engineered nanovesicles mobilize synergistic antitumor immunity by ADAR1 silence and PDL1 blockade.基因工程纳米囊泡通过 ADAR1 沉默和 PDL1 阻断调动协同抗肿瘤免疫。
Mol Ther. 2023 Aug 2;31(8):2489-2506. doi: 10.1016/j.ymthe.2023.04.011. Epub 2023 Apr 23.
10
Neutrophil-Membrane-Coated Biomineralized Metal-Organic Framework Nanoparticles for Atherosclerosis Treatment by Targeting Gene Silencing.中性粒细胞膜包覆的生物矿化金属有机骨架纳米粒子,通过靶向基因沉默治疗动脉粥样硬化。
ACS Nano. 2023 Apr 25;17(8):7721-7732. doi: 10.1021/acsnano.3c00288. Epub 2023 Apr 6.